376 related articles for article (PubMed ID: 15630525)
1. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children.
Shao L; Hill DA; Perlman EJ
Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525
[TBL] [Abstract][Full Text] [Related]
2. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour.
Portugal R; Barroca H
Cytopathology; 2008 Apr; 19(2):80-5. PubMed ID: 17681013
[TBL] [Abstract][Full Text] [Related]
3. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
[TBL] [Abstract][Full Text] [Related]
4. Fine-needle aspiration cytology of clear-cell sarcoma of the kidney: study of eight cases.
Iyer VK; Agarwala S; Verma K
Diagn Cytopathol; 2005 Aug; 33(2):83-9. PubMed ID: 16007650
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center.
Ellison DA; Parham DM; Bridge J; Beckwith JB
Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
7. Classification of malignant pediatric renal tumors by gene expression.
Huang CC; Cutcliffe C; Coffin C; Sorensen PH; Beckwith JB; Perlman EJ;
Pediatr Blood Cancer; 2006 Jun; 46(7):728-38. PubMed ID: 16425275
[TBL] [Abstract][Full Text] [Related]
8. Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney.
Jet Aw S; Hong Kuick C; Hwee Yong M; Wen Quan Lian D; Wang S; Liang Loh AH; Ling S; Lian Peh G; Yen Soh S; Pheng Loh AH; Hoon Tan P; Tou En Chang K
Pediatr Dev Pathol; 2015; 18(4):297-304. PubMed ID: 25751590
[TBL] [Abstract][Full Text] [Related]
9. [New aspects of nephroblastoma (Wilms tumor) and other metanephrogenic neoplasms].
Harms D; Schmidt D; Leuschner I
Verh Dtsch Ges Pathol; 1989; 73():350-71. PubMed ID: 2482620
[TBL] [Abstract][Full Text] [Related]
10. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
11. Role of Cyclin D1 and BCOR Immunohistochemistry in Differentiating Clear Cell Sarcoma of Kidney From its Mimics.
Singh V; Gupta K; Saraswati A; Peters NJ; Trehan A
J Pediatr Hematol Oncol; 2021 Nov; 43(8):294-300. PubMed ID: 34673711
[TBL] [Abstract][Full Text] [Related]
12. The cytological diagnosis of paediatric renal tumours.
Shet T; Viswanathan S
J Clin Pathol; 2009 Nov; 62(11):961-9. PubMed ID: 19700411
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted dysregulation of the epidermal growth factor receptor pathway in clear cell sarcoma of the kidney.
Little SE; Bax DA; Rodriguez-Pinilla M; Natrajan R; Messahel B; Pritchard-Jones K; Vujanic GM; Reis-Filho JS; Jones C
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4360-4. PubMed ID: 17646270
[TBL] [Abstract][Full Text] [Related]
15. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.
Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT
Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496
[TBL] [Abstract][Full Text] [Related]
17. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
19. Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma.
Brownlee NA; Hazen-Martin DJ; Garvin AJ; Re GG
Pediatr Dev Pathol; 2002; 5(3):257-68. PubMed ID: 12007018
[TBL] [Abstract][Full Text] [Related]
20. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.
Miniati D; Gay AN; Parks KV; Naik-Mathuria BJ; Hicks J; Nuchtern JG; Cass DL; Olutoye OO
J Pediatr Surg; 2008 Jul; 43(7):1301-7. PubMed ID: 18639686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]